These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22089354)

  • 1. Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy.
    Stine JG; Bass M; Ibrahim D; Khokhar OS; Lewis JH
    South Med J; 2011 Dec; 104(12):781-8. PubMed ID: 22089354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
    Stine JG; Khokhar OS; Charalambopoulos J; Shanmugam VK; Lewis JH
    Arthritis Care Res (Hoboken); 2010 May; 62(5):704-11. PubMed ID: 20461789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis.
    Motaparthi K; Stanisic V; Van Voorhees AS; Lebwohl MG; Hsu S;
    J Am Acad Dermatol; 2014 Jan; 70(1):178-86. PubMed ID: 24220724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union.
    Smith MY; Attig B; McNamee L; Eagle T
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1168-73. PubMed ID: 22794309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm].
    Terrier B; Pol S; Thibault V; Gottenberg JE; Cacoub P;
    Rev Med Interne; 2012 Jan; 33(1):4-12. PubMed ID: 21889826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Danish nationwide questionnaire study of hepatitis B virus screening before immunosuppressive therapy.
    Bunyoz KI; Krarup H; Weis N
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
    Liu CY; Chandrasekar PH; Masood A; Schiffer CA
    J Oncol Pharm Pract; 2013 Mar; 19(1):18-23. PubMed ID: 22635416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
    Tran TT; Rakoski MO; Martin P; Poordad F
    Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
    Cho YT; Chen CH; Chiu HY; Tsai TF
    J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Shah R; Ho EY; Kramer JR; Richardson P; Sansgiry S; El-Serag HB; Hou JK
    Dig Dis Sci; 2018 Jun; 63(6):1551-1557. PubMed ID: 29663266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?
    Reid CT; De Gascun C; Hall W; Collins P; Lally A; Kirby B
    Br J Dermatol; 2013 Dec; 169(6):1319-21. PubMed ID: 24032395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B reactivation following immunosuppressive therapy and screening adherence: a neglected problem?].
    Borde JP; Kern WV; Becker J; Bertz H; Hübner J; Offensperger WB
    Dtsch Med Wochenschr; 2012 Jul; 137(28-29):1458-62. PubMed ID: 22760404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.
    Wakkee M; Lugtenberg M; Spuls PI; de Jong EM; Thio HB; Westert GP; Nijsten T
    Br J Dermatol; 2008 Aug; 159(2):426-32. PubMed ID: 18616791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
    J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy.
    Chung SJ; Kim JK; Park MC; Park YB; Lee SK
    J Rheumatol; 2009 Nov; 36(11):2416-20. PubMed ID: 19797507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease.
    Cassano N; Mastrandrea V; Principi M; Loconsole F; De Tullio N; Di Leo A; Vena GA
    J Biol Regul Homeost Agents; 2011; 25(2):285-9. PubMed ID: 21880218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].
    Sato K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):161-8. PubMed ID: 21368477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
    Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
    Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Paul S; Shuja A; Tam I; Kim EM; Kang S; Kapulsky L; Viveiros K; Lee H
    Dig Dis Sci; 2016 Aug; 61(8):2236-2241. PubMed ID: 26993822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.